Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gelaspan + Sterofundin ISO is a combination therapy used for intravenous fluid management, particularly in perioperative and critical care settings. It consists of two components:
The combination aims to optimize hemodynamic stability by providing both rapid plasma volume expansion (via the colloid) and physiologically balanced electrolyte replenishment (via the crystalloid). This regimen has demonstrated benefits such as reduced metabolic derangement (less hyperchloremia and acidosis) compared to unbalanced solutions in surgical patients. The mechanism of action involves direct intravascular volume expansion from gelatin polymers (colloid osmotic effect) alongside restoration of extracellular fluid balance with electrolytes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gelaspan + Sterofundin ISO.